During the past decade, University Hospital Olomouc, Clinic of Hemato-Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Olomouc, Clinic of Hemato-Oncology" #1 collaborator was "CZECRIN - Czech Clinical Research Infrastructure Network" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Olomouc, Clinic of Hemato-Oncology" are "Newly Diagnosed" (2 trials), "Acute Lymphoblastic Leukemia, Adult" (1 trials), "Lymphoblastic Leukemia, Acute, Adult" (1 trials), "Multiple Myeloma" (1 trials) and "Ph Negative ALL" (1 trials). Many other conditions were trialed in "University Hospital Olomouc, Clinic of Hemato-Oncology" in a lesser frequency.

Most popular intervention types in "University Hospital Olomouc, Clinic of Hemato-Oncology" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "Blinatumomab" (1 trials), "Melflufen" (1 trials), "Melphalan" (1 trials) and "Ponatinib 15 MG Oral Tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Olomouc, Clinic of Hemato-Oncology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Olomouc, Clinic of Hemato-Oncology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University Hospital Olomouc, Clinic of Hemato-Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Olomouc, Clinic of Hemato-Oncology, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".